Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from JBM (Healthcare) Ltd. ( (HK:2161) ).
JBM (Healthcare) Limited has announced an updated list of its board of directors and their respective roles and committee memberships, effective 30 April 2026. The reshaped governance structure, including clearly designated chairs and members for the audit, remuneration, and nomination committees as well as an executive committee, signals continued emphasis on corporate oversight and governance discipline for shareholders and other stakeholders.
The announcement confirms Mr. Sum Kwong Yip, Derek as Chairman of the Board, Chief Executive Officer, and Executive Director, supported by executive, non-executive, and independent non-executive directors with defined responsibilities across key board committees. This allocation of roles is intended to strengthen checks and balances, ensure regulatory compliance, and support strategic decision-making as the company moves forward under its updated governance framework.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited is a Hong Kong-listed company incorporated in the Cayman Islands and operates in the healthcare sector. The company is governed by a board comprising executive, non-executive, and independent non-executive directors, reflecting a typical listed-company structure focused on corporate governance and oversight.
Average Trading Volume: 333,327
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.98B
See more data about 2161 stock on TipRanks’ Stock Analysis page.